ARCHIVES

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

This article is from The Cancer Letter archive.

Vol. 37 No. 23 | June 10, 2011

Download PDF Visit The Full Archive

Related Articles

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget

April 16, 1993

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

HAI Delivery Extends Survival In Patients With Liver Metastasis

March 31, 2006

Dana-Farber, Harvard And Affiliates Form Cancer Center.

February 4, 2000